Ascendis Pharma AS (ASND)
129.81
+7.17
(+5.85%)
USD |
NASDAQ |
Nov 22, 16:00
134.49
+4.68
(+3.61%)
After-Hours: 20:00
Ascendis Pharma Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 4.975M |
September 30, 2022 | -6.087M |
June 30, 2022 | -5.828M |
March 31, 2022 | 118.00M |
December 31, 2021 | 23.82M |
September 30, 2021 | -433.53M |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 15.89M |
September 30, 2020 | -678.89M |
June 30, 2020 | |
March 31, 2020 | 0.00 |
December 31, 2019 | 45.03M |
September 30, 2019 | 2.813M |
June 30, 2019 | -3.936M |
March 31, 2019 | -581.55M |
Date | Value |
---|---|
December 31, 2018 | -4.980M |
September 30, 2018 | 4.263M |
June 30, 2018 | 3.221M |
March 31, 2018 | -258.01M |
December 31, 2017 | -14.96M |
September 30, 2017 | -135.08M |
June 30, 2017 | -0.0225M |
March 31, 2017 | -0.686M |
December 31, 2016 | -138.70M |
September 30, 2016 | -0.137M |
June 30, 2016 | -0.5773M |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.1865M |
September 30, 2015 | -4.229M |
June 30, 2015 | 1.29M |
March 31, 2015 | -123.91M |
December 31, 2014 | -63.96M |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-678.89M
Minimum
Sep 2020
118.00M
Maximum
Mar 2022
-65.47M
Average
--
Median
Mar 2020
Stock Buybacks (Quarterly) Benchmarks
Novo Nordisk AS | 385.57M |
Evaxion Biotech AS | -- |
Akari Therapeutics PLC | 0.133M |
Biodexa Pharmaceuticals PLC | -- |
TC BioPharm (Holdings) PLC | -0.0251M |